Kolexia
Devaux Madeline
Pharmacien
Hôpital François Mitterrand
Dijon, France
27 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hypoglycémie Tumeurs colorectales Diabète de type 1 Tumeurs de la bouche Myélome multiple Tumeurs gastro-intestinales Lymphomes {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

AstraZeneca
3 collaboration(s)
Dernière en 2023
Janssen
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Baby Margaux's room is still my favorite room in the house ... - Facebook
Facebook   06 novembre 2023
Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.
Cancers   13 septembre 2023
Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring.
Acta diabetologica   13 janvier 2023
Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   29 mai 2022
Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.
Cancers   21 mai 2022
Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer.
World journal of clinical oncology   01 octobre 2020
Safety of ninety-minute daratumumab infusion.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   30 août 2020
Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   16 avril 2020
5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer.
Oncotarget   30 janvier 2018
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}